Clinical trials
Completed Phase 2 Dementia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 7 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 8 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 93 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alkahest, Inc. | 3 |
| Eli Lilly and Company | 3 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 3 |
| AbbVie | 2 |
| Alzheimer's Disease Cooperative Study (ADCS) | 2 |
| Avraham Pharmaceuticals Ltd | 2 |
| Chang Gung Memorial Hospital | 2 |
| Charite University, Berlin, Germany | 2 |
| Eisai Co., Ltd. | 2 |
| Photozig, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 93 |
| Alzheimer Disease | 59 |
| Cognitive Dysfunction | 23 |
| Mental Disorders | 14 |
| Brain Diseases | 12 |
| Central Nervous System Diseases | 11 |
| Memory Disorders | 10 |
| Nervous System Diseases | 10 |
| Neurodegenerative Diseases | 10 |
| Tauopathies | 7 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.